BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 21848624)

  • 1. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
    Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
    Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIT gene exon 11 mutations in canine malignant melanoma.
    Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
    Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-kit expression in canine mucosal melanomas.
    Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF and c-kit gene copy number in mutation-positive malignant melanoma.
    Willmore-Payne C; Holden JA; Hirschowitz S; Layfield LJ
    Hum Pathol; 2006 May; 37(5):520-7. PubMed ID: 16647948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
    Han JI; Kim Y; Kim DY; Na KJ
    Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
    Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
    Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-kit gene mutation and CD117 expression in human anorectal melanomas.
    Ni S; Huang D; Chen X; Huang J; Kong Y; Xu Y; Du X; Sheng W
    Hum Pathol; 2012 Jun; 43(6):801-7. PubMed ID: 22154054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.
    Zavodovskaya R; Liao AT; Jones CL; Yip B; Chien MB; Moore PF; London CA
    Am J Vet Res; 2006 Apr; 67(4):633-41. PubMed ID: 16579756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between KIT Expression and
    Smedley RC; Thaiwong T; Deeth LE; Kiupel M
    Vet Pathol; 2021 Jul; 58(4):683-691. PubMed ID: 33910439
    [No Abstract]   [Full Text] [Related]  

  • 14. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
    Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
    Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?
    Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Martini V; Comazzi S; Dacasto M
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):325-32. PubMed ID: 23375718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
    Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
    Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.